Company Search:
Advanced Search
Sponsored Links
AnGes Inc Company Snapshot
AnGes Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares AnGes Inc with three other companies in this sector in Japan: Raqualia Pharma Incorporated (2018 sales of 744.52 million Japanese Yen [US$6.86 million] of which 100% was Pharmaceutical), Tella Incorporation (516.21 million Japanese Yen [US$4.75 million] of which 71% was Cell Therapy Technology Development Busi), and SanBio Co Ltd (490.51 million Japanese Yen [US$4.52 million] of which 100% was Commercial Physical Research).

Sales Analysis. AnGes Inc reported sales of ¥610.05 million (US$5.62 million) for the year ending December of 2018. This represents an increase of 67.1% versus 2017, when the company's sales were ¥365.18 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
AnGes Inc
  Stock Performance Chart for AnGes Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 709.00
(Figures in Japanese Yen)
1 Week -0.1%   13 Weeks -1.0%  
4 Weeks 20.2%   52 Weeks 75.1%  
AnGes Inc Key Data:
  Ticker: 4563 Country: Japan
  Exchanges: TYO OTH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 610,050,000
(Year Ending Jan 2019).
Employees: 36
  Currency: Japanese Yen Market Cap: 75,841,359,193
  Fiscal Yr Ends: December Shares Outstanding: 106,969,477
  Share Type: Common Closely Held Shares: 3,661,200
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.